- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.03. | FDA approves first generics of anticoagulant Xarelto | ||
| 04.03. | Enhertu extends survival in advanced gastric cancer | ||
| 04.03. | Sofinnova raises €1.2bn to back 'up to 60' companies | ||
| 04.03. | Roche ends the 30-year US hiatus in new stroke drugs | ||
| 04.03. | Pharma urges NHS to put medicines at heart of 10-year plan | ||
| 04.03. | Lilly uses Oscars ad to warn about 'untested' GLP-1s | ||
| 03.03. | Takeda scores with polycythemia vera drug in phase 3 trial | ||
| 03.03. | Australia stands firm on 'no' to Alzheimer's drug Leqembi | ||
| 03.03. | GSK bows to Trump pressure and pauses diversity policies | ||
| 03.03. | UK haemophilia A patients get once-weekly treatment option | ||
| 03.03. | AbbVie pays Gubra $350m upfront to enter obesity field | ||
| 28.02. | Spain agrees to reimburse Orchard's gene therapy Libmeldy | ||
| 28.02. | AbbVie closes on Rinvoq approval in inflamed artery disease | ||
| 28.02. | FDA clears lifesaving feature for Google's Pixel Watch 3 | ||
| 28.02. | Owkin launches ATLANTIS patient data mining project | ||
| 28.02. | Judge blocks mass firings of federal agency workers | ||
| 27.02. | Indivior changes CEO after warning sales will fall in 2025 | ||
| 27.02. | Regeneron tries again with lymphoma bispecific in US | ||
| 27.02. | Kyorin partners Hyfe to develop DTx for chronic cough | ||
| 27.02. | Vaccine sector on edge as HHS cancels flu meeting | ||
| 26.02. | Lilly unveils $27bn reshoring drive around four new plants | ||
| 26.02. | Perlmutter's Eikon raises $351m in major financing round | ||
| 26.02. | Can Keytruda finally break into early head and neck cancer? | ||
| 26.02. | Why non-diabetics using CGM may not be a good idea | ||
| 26.02. | Bayer reveals phase 3 data for improved MRI contrast agent |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
